Vertically integrated cannabis company Sunniva (CSE: SNN) (OTCQX: SNNVF) this morning announced that its wholly owned subsidiary, Sunniva Medical Inc. (“SMI”), has received the Confirmation of Readiness from Health Canada for a license under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). Now that the application has been accepted, the next step will be an inspection upon site readiness to begin cultivation. SMI will be required to provide information including documentation, photos, and videos of the Sunniva Canada Campus to present evidence of all physical security measures in order to confirm readiness and receive a cultivation license from Health Canada. Additionally, SMI has received development approval from the Regional District of Okanagan-Similkameen for construction of the Sunniva Canada Campus on its recently-purchased 126-acre site in Okanagan Falls, British Columbia. “We are pleased to deliver on another key corporate milestone for the company as we have made an excellent start to 2018 with significant progress on multiple fronts, executing on our strategy, and working toward our goal of creating one of the most efficient, low-cost growing operations to serve the Canadian and California cannabis market,” Sunniva CEO Dr. Anthony Holler stated in the news release. “It is our intention to forward sell an additional 30% of our production capacity in Canada”.
To view the full press release, visit http://cnw.fm/ML76r
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – where it is committed to delivering safe, high-quality products and services at scale. The company’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built current good manufacturing practices greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries. For more information, visit the company’s website at www.Sunniva.com.
More from CannabisNewsBreaks
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net